1. Home
  2. PHVS vs NESR Comparison

PHVS vs NESR Comparison

Compare PHVS & NESR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHVS
  • NESR
  • Stock Information
  • Founded
  • PHVS 2015
  • NESR 2017
  • Country
  • PHVS Netherlands
  • NESR United States
  • Employees
  • PHVS N/A
  • NESR N/A
  • Industry
  • PHVS Biotechnology: Pharmaceutical Preparations
  • NESR
  • Sector
  • PHVS Health Care
  • NESR
  • Exchange
  • PHVS Nasdaq
  • NESR NYSE
  • Market Cap
  • PHVS 862.3M
  • NESR 895.3M
  • IPO Year
  • PHVS 2021
  • NESR N/A
  • Fundamental
  • Price
  • PHVS $16.91
  • NESR $7.46
  • Analyst Decision
  • PHVS Strong Buy
  • NESR Strong Buy
  • Analyst Count
  • PHVS 5
  • NESR 4
  • Target Price
  • PHVS $41.60
  • NESR $15.00
  • AVG Volume (30 Days)
  • PHVS 50.2K
  • NESR 215.3K
  • Earning Date
  • PHVS 05-07-2025
  • NESR 03-12-2025
  • Dividend Yield
  • PHVS N/A
  • NESR N/A
  • EPS Growth
  • PHVS N/A
  • NESR 514.84
  • EPS
  • PHVS N/A
  • NESR 0.80
  • Revenue
  • PHVS N/A
  • NESR $1,301,704,000.00
  • Revenue This Year
  • PHVS N/A
  • NESR $10.16
  • Revenue Next Year
  • PHVS N/A
  • NESR $7.46
  • P/E Ratio
  • PHVS N/A
  • NESR $9.22
  • Revenue Growth
  • PHVS N/A
  • NESR 13.60
  • 52 Week Low
  • PHVS $14.14
  • NESR $7.30
  • 52 Week High
  • PHVS $26.57
  • NESR $9.89
  • Technical
  • Relative Strength Index (RSI)
  • PHVS 55.23
  • NESR N/A
  • Support Level
  • PHVS $14.49
  • NESR N/A
  • Resistance Level
  • PHVS $17.00
  • NESR N/A
  • Average True Range (ATR)
  • PHVS 1.32
  • NESR 0.00
  • MACD
  • PHVS 0.18
  • NESR 0.00
  • Stochastic Oscillator
  • PHVS 71.95
  • NESR 0.00

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

About NESR NATIONAL ENERGY SVCS REUNITED CORP

National Energy Services Reunited Corp is a British Virgin Islands-based company engaged in providing products and services to the oil and gas industry in the Middle East and North Africa and the Asia Pacific regions. The company has two reportable segments: Production Services including coil tubing, stimulation, and pumping, nitrogen services, completions, pipelines, cementing, laboratory services and filtration services; and Drilling and Evaluation Services including drilling and workover rigs, rig services, services, and well-testing services among others. Revenues are majorly derived from production services of an oil or natural gas well.

Share on Social Networks: